246 Users Online
Cutaneous Squamous Cell Carcinoma Market Segmented By Surgical, Non-surgical Treatment with Distributional Channel in Hospitals, Cancer Institutes, Ambulatory Surgical Centers
Cutaneous squamous cell carcinoma is a most common type of non-melanoma or keratinocyte skin cancer. It is an invasive disease that grow beyond the epidermis. Cutaneous squamous cell carcinoma is a type of cancer which results in malignant proliferation of cutaneous epithelium indicating 20% to 50% skin cancer.
Cutaneous squamous cell carcinoma is associated with substantial risk of metastasis. Cumulative exposure to sunlight, exposure to X-ray or certain other chemicals are the prime factors for developing of cutaneous squamous cell carcinoma.
According to Skin Cancer Foundation report, 2019, more than 9,500 people are diagnosed with skin cancer every day in US. Apart from this, according to American Cancer Society 2019 statistics, an estimate of 5.4 million squamous and basal cell skin cancers are diagnosed each year in US.
The cutaneous squamous cell carcinoma market is expected to register significant growth in the market owing to increase in prevalence of cutaneous squamous cell carcinoma, advancement in research and development in developing novel therapeutics, increasing launch of new drugs into the market, rising pipeline portfolio of various companies are some of the factor which will drive the cutaneous squamous cell carcinoma market.
However, increase in complications rate, lack of early detection of the diseases may hamper the growth of the cutaneous squamous cell carcinoma market. Moreover, cost associated with branded drugs and lack of health insurance in developing countries may also hinder the growth of the cutaneous squamous cell carcinoma market.